Global Swine Influenza Vaccines Market Research Report 2023

Global Swine Influenza Vaccines Market Research Report 2023

Table of Contents
1 Swine Influenza Vaccines Market Overview
1.1 Product Overview and Scope of Swine Influenza Vaccines
1.2 Swine Influenza Vaccines Segment by Type
1.2.1 Global Swine Influenza Vaccines Market Value Comparison by Type (2023-2029)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Swine Influenza Vaccines Segment by Application
1.3.1 Global Swine Influenza Vaccines Market Value by Application: (2023-2029)
1.3.2 Commodity Pig
1.3.3 Breeding Pig
1.4 Global Swine Influenza Vaccines Market Size Estimates and Forecasts
1.4.1 Global Swine Influenza Vaccines Revenue 2018-2029
1.4.2 Global Swine Influenza Vaccines Sales 2018-2029
1.4.3 Global Swine Influenza Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Swine Influenza Vaccines Market Competition by Manufacturers
2.1 Global Swine Influenza Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Swine Influenza Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Swine Influenza Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Swine Influenza Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Swine Influenza Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Swine Influenza Vaccines, Product Type & Application
2.7 Swine Influenza Vaccines Market Competitive Situation and Trends
2.7.1 Swine Influenza Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Swine Influenza Vaccines Players Market Share by Revenue
2.7.3 Global Swine Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Swine Influenza Vaccines Retrospective Market Scenario by Region
3.1 Global Swine Influenza Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Swine Influenza Vaccines Global Swine Influenza Vaccines Sales by Region: 2018-2029
3.2.1 Global Swine Influenza Vaccines Sales by Region: 2018-2023
3.2.2 Global Swine Influenza Vaccines Sales by Region: 2024-2029
3.3 Global Swine Influenza Vaccines Global Swine Influenza Vaccines Revenue by Region: 2018-2029
3.3.1 Global Swine Influenza Vaccines Revenue by Region: 2018-2023
3.3.2 Global Swine Influenza Vaccines Revenue by Region: 2024-2029
3.4 North America Swine Influenza Vaccines Market Facts & Figures by Country
3.4.1 North America Swine Influenza Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Swine Influenza Vaccines Sales by Country (2018-2029)
3.4.3 North America Swine Influenza Vaccines Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Swine Influenza Vaccines Market Facts & Figures by Country
3.5.1 Europe Swine Influenza Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Swine Influenza Vaccines Sales by Country (2018-2029)
3.5.3 Europe Swine Influenza Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Swine Influenza Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Swine Influenza Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Swine Influenza Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Swine Influenza Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Swine Influenza Vaccines Market Facts & Figures by Country
3.7.1 Latin America Swine Influenza Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Swine Influenza Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Swine Influenza Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Swine Influenza Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Swine Influenza Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Swine Influenza Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Swine Influenza Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Swine Influenza Vaccines Sales by Type (2018-2029)
4.1.1 Global Swine Influenza Vaccines Sales by Type (2018-2023)
4.1.2 Global Swine Influenza Vaccines Sales by Type (2024-2029)
4.1.3 Global Swine Influenza Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Swine Influenza Vaccines Revenue by Type (2018-2029)
4.2.1 Global Swine Influenza Vaccines Revenue by Type (2018-2023)
4.2.2 Global Swine Influenza Vaccines Revenue by Type (2024-2029)
4.2.3 Global Swine Influenza Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Swine Influenza Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Swine Influenza Vaccines Sales by Application (2018-2029)
5.1.1 Global Swine Influenza Vaccines Sales by Application (2018-2023)
5.1.2 Global Swine Influenza Vaccines Sales by Application (2024-2029)
5.1.3 Global Swine Influenza Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Swine Influenza Vaccines Revenue by Application (2018-2029)
5.2.1 Global Swine Influenza Vaccines Revenue by Application (2018-2023)
5.2.2 Global Swine Influenza Vaccines Revenue by Application (2024-2029)
5.2.3 Global Swine Influenza Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Swine Influenza Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Chengdu TECBOND
6.1.1 Chengdu TECBOND Corporation Information
6.1.2 Chengdu TECBOND Description and Business Overview
6.1.3 Chengdu TECBOND Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Chengdu TECBOND Swine Influenza Vaccines Product Portfolio
6.1.5 Chengdu TECBOND Recent Developments/Updates
6.2 Green Cross Veterinary
6.2.1 Green Cross Veterinary Corporation Information
6.2.2 Green Cross Veterinary Description and Business Overview
6.2.3 Green Cross Veterinary Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Green Cross Veterinary Swine Influenza Vaccines Product Portfolio
6.2.5 Green Cross Veterinary Recent Developments/Updates
6.3 Hipra
6.3.1 Hipra Corporation Information
6.3.2 Hipra Description and Business Overview
6.3.3 Hipra Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Hipra Swine Influenza Vaccines Product Portfolio
6.3.5 Hipra Recent Developments/Updates
6.4 MSD Animal Health (Merck)
6.4.1 MSD Animal Health (Merck) Corporation Information
6.4.2 MSD Animal Health (Merck) Description and Business Overview
6.4.3 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 MSD Animal Health (Merck) Swine Influenza Vaccines Product Portfolio
6.4.5 MSD Animal Health (Merck) Recent Developments/Updates
6.5 Zoetis
6.5.1 Zoetis Corporation Information
6.5.2 Zoetis Description and Business Overview
6.5.3 Zoetis Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Zoetis Swine Influenza Vaccines Product Portfolio
6.5.5 Zoetis Recent Developments/Updates
6.6 CAHIC
6.6.1 CAHIC Corporation Information
6.6.2 CAHIC Description and Business Overview
6.6.3 CAHIC Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 CAHIC Swine Influenza Vaccines Product Portfolio
6.6.5 CAHIC Recent Developments/Updates
6.7 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Boehringer Ingelheim Swine Influenza Vaccines Product Portfolio
6.7.5 Boehringer Ingelheim Recent Developments/Updates
6.8 Ceva
6.8.1 Ceva Corporation Information
6.8.2 Ceva Description and Business Overview
6.8.3 Ceva Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Ceva Swine Influenza Vaccines Product Portfolio
6.8.5 Ceva Recent Developments/Updates
6.9 Ringpu Biology
6.9.1 Ringpu Biology Corporation Information
6.9.2 Ringpu Biology Description and Business Overview
6.9.3 Ringpu Biology Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Ringpu Biology Swine Influenza Vaccines Product Portfolio
6.9.5 Ringpu Biology Recent Developments/Updates
6.10 DHN
6.10.1 DHN Corporation Information
6.10.2 DHN Description and Business Overview
6.10.3 DHN Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.10.4 DHN Swine Influenza Vaccines Product Portfolio
6.10.5 DHN Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Swine Influenza Vaccines Industry Chain Analysis
7.2 Swine Influenza Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Swine Influenza Vaccines Production Mode & Process
7.4 Swine Influenza Vaccines Sales and Marketing
7.4.1 Swine Influenza Vaccines Sales Channels
7.4.2 Swine Influenza Vaccines Distributors
7.5 Swine Influenza Vaccines Customers
8 Swine Influenza Vaccines Market Dynamics
8.1 Swine Influenza Vaccines Industry Trends
8.2 Swine Influenza Vaccines Market Drivers
8.3 Swine Influenza Vaccines Market Challenges
8.4 Swine Influenza Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Swine Influenza Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Swine Influenza Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Swine Influenza Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Swine Influenza Vaccines Sales (M Units) of Key Manufacturers (2018-2023)
Table 5. Global Swine Influenza Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Swine Influenza Vaccines Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Swine Influenza Vaccines Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Swine Influenza Vaccines Average Price (USD/K Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Swine Influenza Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Swine Influenza Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Swine Influenza Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Swine Influenza Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Swine Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Influenza Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Swine Influenza Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Swine Influenza Vaccines Sales by Region (2018-2023) & (M Units)
Table 18. Global Swine Influenza Vaccines Sales Market Share by Region (2018-2023)
Table 19. Global Swine Influenza Vaccines Sales by Region (2024-2029) & (M Units)
Table 20. Global Swine Influenza Vaccines Sales Market Share by Region (2024-2029)
Table 21. Global Swine Influenza Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Swine Influenza Vaccines Revenue Market Share by Region (2018-2023)
Table 23. Global Swine Influenza Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Swine Influenza Vaccines Revenue Market Share by Region (2024-2029)
Table 25. North America Swine Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Swine Influenza Vaccines Sales by Country (2018-2023) & (M Units)
Table 27. North America Swine Influenza Vaccines Sales by Country (2024-2029) & (M Units)
Table 28. North America Swine Influenza Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Swine Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Swine Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Swine Influenza Vaccines Sales by Country (2018-2023) & (M Units)
Table 32. Europe Swine Influenza Vaccines Sales by Country (2024-2029) & (M Units)
Table 33. Europe Swine Influenza Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Swine Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Swine Influenza Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Swine Influenza Vaccines Sales by Region (2018-2023) & (M Units)
Table 37. Asia Pacific Swine Influenza Vaccines Sales by Region (2024-2029) & (M Units)
Table 38. Asia Pacific Swine Influenza Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Swine Influenza Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Swine Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Swine Influenza Vaccines Sales by Country (2018-2023) & (M Units)
Table 42. Latin America Swine Influenza Vaccines Sales by Country (2024-2029) & (M Units)
Table 43. Latin America Swine Influenza Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Swine Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Swine Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Swine Influenza Vaccines Sales by Country (2018-2023) & (M Units)
Table 47. Middle East & Africa Swine Influenza Vaccines Sales by Country (2024-2029) & (M Units)
Table 48. Middle East & Africa Swine Influenza Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Swine Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Swine Influenza Vaccines Sales (M Units) by Type (2018-2023)
Table 51. Global Swine Influenza Vaccines Sales (M Units) by Type (2024-2029)
Table 52. Global Swine Influenza Vaccines Sales Market Share by Type (2018-2023)
Table 53. Global Swine Influenza Vaccines Sales Market Share by Type (2024-2029)
Table 54. Global Swine Influenza Vaccines Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Swine Influenza Vaccines Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Swine Influenza Vaccines Revenue Market Share by Type (2018-2023)
Table 57. Global Swine Influenza Vaccines Revenue Market Share by Type (2024-2029)
Table 58. Global Swine Influenza Vaccines Price (USD/K Unit) by Type (2018-2023)
Table 59. Global Swine Influenza Vaccines Price (USD/K Unit) by Type (2024-2029)
Table 60. Global Swine Influenza Vaccines Sales (M Units) by Application (2018-2023)
Table 61. Global Swine Influenza Vaccines Sales (M Units) by Application (2024-2029)
Table 62. Global Swine Influenza Vaccines Sales Market Share by Application (2018-2023)
Table 63. Global Swine Influenza Vaccines Sales Market Share by Application (2024-2029)
Table 64. Global Swine Influenza Vaccines Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Swine Influenza Vaccines Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Swine Influenza Vaccines Revenue Market Share by Application (2018-2023)
Table 67. Global Swine Influenza Vaccines Revenue Market Share by Application (2024-2029)
Table 68. Global Swine Influenza Vaccines Price (USD/K Unit) by Application (2018-2023)
Table 69. Global Swine Influenza Vaccines Price (USD/K Unit) by Application (2024-2029)
Table 70. Chengdu TECBOND Corporation Information
Table 71. Chengdu TECBOND Description and Business Overview
Table 72. Chengdu TECBOND Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2023)
Table 73. Chengdu TECBOND Swine Influenza Vaccines Product
Table 74. Chengdu TECBOND Recent Developments/Updates
Table 75. Green Cross Veterinary Corporation Information
Table 76. Green Cross Veterinary Description and Business Overview
Table 77. Green Cross Veterinary Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2023)
Table 78. Green Cross Veterinary Swine Influenza Vaccines Product
Table 79. Green Cross Veterinary Recent Developments/Updates
Table 80. Hipra Corporation Information
Table 81. Hipra Description and Business Overview
Table 82. Hipra Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2023)
Table 83. Hipra Swine Influenza Vaccines Product
Table 84. Hipra Recent Developments/Updates
Table 85. MSD Animal Health (Merck) Corporation Information
Table 86. MSD Animal Health (Merck) Description and Business Overview
Table 87. MSD Animal Health (Merck) Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2023)
Table 88. MSD Animal Health (Merck) Swine Influenza Vaccines Product
Table 89. MSD Animal Health (Merck) Recent Developments/Updates
Table 90. Zoetis Corporation Information
Table 91. Zoetis Description and Business Overview
Table 92. Zoetis Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2023)
Table 93. Zoetis Swine Influenza Vaccines Product
Table 94. Zoetis Recent Developments/Updates
Table 95. CAHIC Corporation Information
Table 96. CAHIC Description and Business Overview
Table 97. CAHIC Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2023)
Table 98. CAHIC Swine Influenza Vaccines Product
Table 99. CAHIC Recent Developments/Updates
Table 100. Boehringer Ingelheim Corporation Information
Table 101. Boehringer Ingelheim Description and Business Overview
Table 102. Boehringer Ingelheim Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2023)
Table 103. Boehringer Ingelheim Swine Influenza Vaccines Product
Table 104. Boehringer Ingelheim Recent Developments/Updates
Table 105. Ceva Corporation Information
Table 106. Ceva Description and Business Overview
Table 107. Ceva Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2023)
Table 108. Ceva Swine Influenza Vaccines Product
Table 109. Ceva Recent Developments/Updates
Table 110. Ringpu Biology Corporation Information
Table 111. Ringpu Biology Description and Business Overview
Table 112. Ringpu Biology Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2023)
Table 113. Ringpu Biology Swine Influenza Vaccines Product
Table 114. Ringpu Biology Recent Developments/Updates
Table 115. DHN Corporation Information
Table 116. DHN Description and Business Overview
Table 117. DHN Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2023)
Table 118. DHN Swine Influenza Vaccines Product
Table 119. DHN Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Swine Influenza Vaccines Distributors List
Table 123. Swine Influenza Vaccines Customers List
Table 124. Swine Influenza Vaccines Market Trends
Table 125. Swine Influenza Vaccines Market Drivers
Table 126. Swine Influenza Vaccines Market Challenges
Table 127. Swine Influenza Vaccines Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Swine Influenza Vaccines
Figure 2. Global Swine Influenza Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Swine Influenza Vaccines Market Share by Type in 2022 & 2029
Figure 4. Live Vaccines Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global Swine Influenza Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Swine Influenza Vaccines Market Share by Application in 2022 & 2029
Figure 8. Commodity Pig
Figure 9. Breeding Pig
Figure 10. Global Swine Influenza Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Swine Influenza Vaccines Market Size (2018-2029) & (US$ Million)
Figure 12. Global Swine Influenza Vaccines Sales (2018-2029) & (M Units)
Figure 13. Global Swine Influenza Vaccines Average Price (USD/K Unit) & (2018-2029)
Figure 14. Swine Influenza Vaccines Report Years Considered
Figure 15. Swine Influenza Vaccines Sales Share by Manufacturers in 2022
Figure 16. Global Swine Influenza Vaccines Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Swine Influenza Vaccines Players: Market Share by Revenue in 2022
Figure 18. Swine Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Swine Influenza Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Swine Influenza Vaccines Sales Market Share by Country (2018-2029)
Figure 21. North America Swine Influenza Vaccines Revenue Market Share by Country (2018-2029)
Figure 22. the United States Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Swine Influenza Vaccines Sales Market Share by Country (2018-2029)
Figure 25. Europe Swine Influenza Vaccines Revenue Market Share by Country (2018-2029)
Figure 26. Germany Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. UK Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Swine Influenza Vaccines Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Swine Influenza Vaccines Revenue Market Share by Region (2018-2029)
Figure 33. China Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Swine Influenza Vaccines Sales Market Share by Country (2018-2029)
Figure 43. Latin America Swine Influenza Vaccines Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Swine Influenza Vaccines Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Swine Influenza Vaccines Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Swine Influenza Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Swine Influenza Vaccines by Type (2018-2029)
Figure 53. Global Revenue Market Share of Swine Influenza Vaccines by Type (2018-2029)
Figure 54. Global Swine Influenza Vaccines Price (USD/K Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Swine Influenza Vaccines by Application (2018-2029)
Figure 56. Global Revenue Market Share of Swine Influenza Vaccines by Application (2018-2029)
Figure 57. Global Swine Influenza Vaccines Price (USD/K Unit) by Application (2018-2029)
Figure 58. Swine Influenza Vaccines Value Chain
Figure 59. Swine Influenza Vaccines Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Classical Swine Fever Vaccines Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......

Global Tylosin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......

Global Animal Parasiticides Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......

Global Newcastle Disease Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......

Global Classical Swine Fever Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126

According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......

Global Veterinary Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151

According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......

Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......

Global Veterinary Products for Companion Animals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......

Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115

According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs